Characteristics | SLE (n= 63) | Control (n= 33) |
---|---|---|
Age, median (range), years | 42 (19 to 81) | 45 (24 to 79) |
Female, % | 94 | 85 |
Male, % | 6 | 15 |
Disease duration, median (range), years | 8 (0 to 45) | - |
SLEDAI score, median (range) | 2 (0 to 18) | - |
Seizure | 0 | - |
Psychosis | 0 | - |
Organic brain syndrome | 0 | - |
Visual disturbance | 1 | - |
Cranial nerve disorder | 1 | - |
Lupus headache | 0 | - |
Cerebrovascular accident | 0 | - |
Vasculitis | 3 | - |
Arthritis | 8 | - |
Myositis | 1 | - |
Kidney involvement (urinary cast, hematuria, proteinuria or pyuria) | 14 | - |
Mucocutaneous activity (rash, alopecia or mucosal ulcers) | 12 | - |
Pleurisy | 0 | - |
Pericarditis | 0 | - |
Low complement (C3 or C4) | 14 | - |
Anti-DNA antibodies | 14 | - |
Fever | 2 | - |
Thrombocytopenia | 1 | - |
Leukopenia | 2 | - |